Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Aberrant intestinal microbiota due to IL-1 receptor antagonist deficiency promotes IL-17- and TLR4-dependent arthritis.

Rogier R, Ederveen THA, Boekhorst J, Wopereis H, Scher JU, Manasson J, Frambach SJCM, Knol J, Garssen J, van der Kraan PM, Koenders MI, van den Berg WB, van Hijum SAFT, Abdollahi-Roodsaz S.

Microbiome. 2017 Jun 23;5(1):63. doi: 10.1186/s40168-017-0278-2.

2.

Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) Survey: Benefits and Challenges of Combined Rheumatology-dermatology Clinics.

Okhovat JP, Ogdie A, Reddy SM, Rosen CF, Scher JU, Merola JF.

J Rheumatol. 2017 May;44(5):693-694. doi: 10.3899/jrheum.170148.

PMID:
28461529
3.

The lung microbiota in early rheumatoid arthritis and autoimmunity.

Scher JU, Joshua V, Artacho A, Abdollahi-Roodsaz S, Öckinger J, Kullberg S, Sköld M, Eklund A, Grunewald J, Clemente JC, Ubeda C, Segal LN, Catrina AI.

Microbiome. 2016 Nov 17;4(1):60.

4.

Short- and long-term effects of oral vancomycin on the human intestinal microbiota.

Isaac S, Scher JU, Djukovic A, Jiménez N, Littman DR, Abramson SB, Pamer EG, Ubeda C.

J Antimicrob Chemother. 2017 Jan;72(1):128-136. Epub 2016 Oct 5.

5.

The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions.

Abdollahi-Roodsaz S, Abramson SB, Scher JU.

Nat Rev Rheumatol. 2016 Aug;12(8):446-55. doi: 10.1038/nrrheum.2016.68. Epub 2016 Jun 3. Review.

PMID:
27256713
6.

The microbiome in celiac disease: Beyond diet-genetic interactions.

Scher JU.

Cleve Clin J Med. 2016 Mar;83(3):228-30. doi: 10.3949/ccjm.83a.15123. No abstract available.

7.

Reply.

Scher JU, Abramson SB.

Arthritis Rheumatol. 2016 Jun;68(6):1569-70. doi: 10.1002/art.39644. No abstract available.

8.

Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases.

Scher JU, Littman DR, Abramson SB.

Arthritis Rheumatol. 2016 Jan;68(1):35-45. doi: 10.1002/art.39259. Review. No abstract available.

9.

Reply: To PMID 25319745.

Scher JU, Reddy S, Ubeda C, Neimann A, Abramson SB.

Arthritis Rheumatol. 2015 May;67(8):2280-2. doi: 10.1002/art.39152. No abstract available.

10.

Erratum to: Analysis of Programmed Death-1 in Patients with Psoriatic Arthritis.

Peled M, Strazza M, Azoulay-Alfaguter I, Silverman GJ, Scher JU, Mor A.

Inflammation. 2015 Aug;38(4):1580. doi: 10.1007/s10753-015-0165-6. No abstract available.

PMID:
25847627
11.

Intestinal dysbiosis and potential consequences of microbiome-altering antibiotic use in the pathogenesis of human rheumatic disease.

Scher JU.

J Rheumatol. 2015 Mar;42(3):355-7. doi: 10.3899/jrheum.150036. No abstract available.

PMID:
25729039
12.

Analysis of Programmed Death-1 in Patients with Psoriatic Arthritis.

Peled M, Strazza M, Azoulay-Alfaguter I, Silverman GJ, Scher JU, Mor A.

Inflammation. 2015 Aug;38(4):1573-9. doi: 10.1007/s10753-015-0132-2. Erratum in: Inflammation. 2015 Aug;38(4):1580. Silverman, Gregg J [added]; Scher, Jose U [added].

PMID:
25663558
13.

Spondyloarthritis and the microbiome: new insights from an ancient hypothesis.

Manasson J, Scher JU.

Curr Rheumatol Rep. 2015 Feb;17(2):10. doi: 10.1007/s11926-014-0487-7. Review.

PMID:
25663180
14.

Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis.

Catrina AI, Deane KD, Scher JU.

Rheumatology (Oxford). 2016 Mar;55(3):391-402. doi: 10.1093/rheumatology/keu469. Epub 2014 Dec 23. Review.

15.

Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism.

Zanin-Zhorov A, Weiss JM, Nyuydzefe MS, Chen W, Scher JU, Mo R, Depoil D, Rao N, Liu B, Wei J, Lucas S, Koslow M, Roche M, Schueller O, Weiss S, Poyurovsky MV, Tonra J, Hippen KL, Dustin ML, Blazar BR, Liu CJ, Waksal SD.

Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16814-9. doi: 10.1073/pnas.1414189111. Epub 2014 Nov 10.

16.

Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease.

Scher JU, Ubeda C, Artacho A, Attur M, Isaac S, Reddy SM, Marmon S, Neimann A, Brusca S, Patel T, Manasson J, Pamer EG, Littman DR, Abramson SB.

Arthritis Rheumatol. 2015 Jan;67(1):128-39. doi: 10.1002/art.38892.

17.

Biomarkers in psoriatic arthritis: recent progress.

Chandran V, Scher JU.

Curr Rheumatol Rep. 2014 Nov;16(11):453. doi: 10.1007/s11926-014-0453-4. Review.

PMID:
25218735
18.

Periodontal disease and subgingival microbiota as contributors for rheumatoid arthritis pathogenesis: modifiable risk factors?

Scher JU, Bretz WA, Abramson SB.

Curr Opin Rheumatol. 2014 Jul;26(4):424-9. doi: 10.1097/BOR.0000000000000076. Review.

19.

Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity.

Brusca SB, Abramson SB, Scher JU.

Curr Opin Rheumatol. 2014 Jan;26(1):101-7. doi: 10.1097/BOR.0000000000000008. Review.

Supplemental Content

Loading ...
Support Center